<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35934258</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN><JournalIssue CitedMedium="Internet"><Volume>319</Volume><PubDate><Year>2022</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Virus research</Title><ISOAbbreviation>Virus Res</ISOAbbreviation></Journal><ArticleTitle>Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19.</ArticleTitle><Pagination><StartPage>198882</StartPage><MedlinePgn>198882</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2022.198882</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-1702(22)00210-6</ELocationID><Abstract><AbstractText>To date, a total of seven human coronaviruses (HCoVs) have been identified, all of which are important respiratory pathogens. Recently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global pandemic causing millions of infections and deaths. Here, we summarize the discovery and fundamental virology of HCoVs, discuss their zoonotic transmission and highlight the weak species barrier of SARS-CoV-2. We also discuss the possible origins of SARS-CoV-2 variants of concern identified to date and discuss the experimental challenges in characterizing mutations of interest and propose methods to circumvent them. As the COVID-19 treatment and prevention landscape rapidly evolves, we summarize current therapeutics and vaccines, and their implications on SARS-CoV-2 variants. Finally, we explore how interspecies transmission of SARS-CoV-2 may drive the emergence of novel strains, how disease severity may evolve and how COVID-19 will likely continue to burden healthcare systems globally.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>Magan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada. Electronic address: chen.liang@mcgill.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virus Res</MedlineTA><NlmUniqueID>8410979</NlmUniqueID><ISSNLinking>0168-1702</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cross-species transmission</Keyword><Keyword MajorTopicYN="N">Human coronaviruses</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vaccines</Keyword><Keyword MajorTopicYN="N">Variants of concern</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>7</Day><Hour>19</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35934258</ArticleId><ArticleId IdType="pmc">PMC9351210</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2022.198882</ArticleId><ArticleId IdType="pii">S0168-1702(22)00210-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ader F., Bouscambert-Duchamp M., Hites M., Peiffer-Smadja N., Poissy J., Belhadi D., Diallo A., L&#xea; M.P., Peytavin G., Staub T., Greil R., Guedj J., Paiva J.A., Costagliola D., Yazdanpanah Y., Burdet C., Mentr&#xe9; F., Egle A., Greil R., Joannidis M., Lamprecht B., Altdorfer A., Belkhir L., Fraipont V., Hites M., Verschelden G., Aboab J., Ader F., Ait-Oufella H., Andrejak C., Andreu P., Argaud L., Bani-Sadr F., Benezit F., Blot M., Botelho-Nevers E., Bouadma L., Bouchaud O., Bougon D., Bouiller K., Bounes-Vardon F., Boutoille D., Boyer A., Bruel C., Cabi&#xe9; A., Canet E., Cazanave C., Chabartier C., Chirouze C., Clere-Jehl R., et al. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Lancet Infect. Dis. 2021 doi: 10.1016/S1473-3099(21)00485-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00485-0</ArticleId><ArticleId IdType="pmc">PMC8439621</ArticleId><ArticleId IdType="pubmed">34534511</ArticleId></ArticleIdList></Reference><Reference><Citation>Agostini M.L., Andres E.L., Sims A.C., Graham R.L., Sheahan T.P., Lu X., Smith E.C., Case J.B., Feng J.Y., Jordan R., Ray A.S., Cihlar T., Siegel D., Mackman R.L., MO Clarke, Baric R.S., Denison M.R. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio. 2018;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5844999</ArticleId><ArticleId IdType="pubmed">29511076</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhatib M., Svicher V., Salpini R., Ambrosio F.A., Bellocchi M.C., Carioti L., Piermatteo L., Scutari R., Costa G., Artese A., Alcaro S., Shafer R., Ceccherini-Silberstein F., Perez D.R. SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021. Microbiol. Spectr. 2021;9 e01096-21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8597642</ArticleId><ArticleId IdType="pubmed">34787497</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaz&#xe1;n F., Gonz&#xe1;lez J.M., P&#xe9;nzes Z., Izeta A., Calvo E., Plana-Dur&#xe1;n J., Enjuanes L. Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. 2000;97:5516&#x2013;5521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC25860</ArticleId><ArticleId IdType="pubmed">10805807</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaz&#xe1;n F., Sola I., Zu&#xf1;iga S., Marquez-Jurado S., Morales L., Becares M., Enjuanes L. Coronavirus reverse genetic systems: infectious clones and replicons. Virus Res. 2014;189:262&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4727449</ArticleId><ArticleId IdType="pubmed">24930446</ArticleId></ArticleIdList></Reference><Reference><Citation>Asundi A., O'Leary C., Bhadelia N. Global COVID-19 vaccine inequity: the scope, the impact, and the challenges. Cell Host Microbe. 2021;29:1036&#x2013;1039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8279498</ArticleId><ArticleId IdType="pubmed">34265241</ArticleId></ArticleIdList></Reference><Reference><Citation>Avanzato V.A., Matson M.J., Seifert S.N., Pryce R., Williamson B.N., Anzick S.L., Barbian K., Judson S.D., Fischer E.R., Martens C. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell. 2020;183:1901&#x2013;1912. e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7640888</ArticleId><ArticleId IdType="pubmed">33248470</ArticleId></ArticleIdList></Reference><Reference><Citation>Banu S., Jolly B., Mukherjee P., Singh P., Khan S., Zaveri L., Shambhavi S., Gaur N., Reddy S., Kaveri K. (2020). A Distinct Phylogenetic Cluster of Indian Severe Acute Respiratory Syndrome Coronavirus 2 Isolates, p ofaa434, Oxford University Press US.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543508</ArticleId><ArticleId IdType="pubmed">33200080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayarri-Olmos R., Rosbjerg A., Johnsen L.B., Helgstrand C., Bak-Thomsen T., Garred P., Skjoedt M.-.O. The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization. J. Biol. Chem. 2021;296</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948531</ArticleId><ArticleId IdType="pubmed">33716040</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigel J.H., Tomashek K.M., Dodd L.E., Mehta A.K., Zingman B.S., Kalil A.C., Hohmann E., Chu H.Y., Luetkemeyer A., Kline S., Lopez de Castilla D., Finberg R.W., Dierberg K., Tapson V., Hsieh L., Patterson T.F., Paredes R., Sweeney D.A., Short W.R., Touloumi G., Lye D.C., Ohmagari N., Oh M.D., Ruiz-Palacios G.M., Benfield T., F&#xe4;tkenheuer G., Kortepeter M.G., Atmar R.L., Creech C.B., Lundgren J., Babiker A.G., Pett S., Neaton J.D., Burgess T.H., Bonnett T., Green M., Makowski M., Osinusi A., Nayak S., Lane H.C. Remdesivir for the treatment of COVID-19 &#x2014; final report. N. Engl. J. Med. 2020;383:1813&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262788</ArticleId><ArticleId IdType="pubmed">32445440</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradburne A.F., Bynoe M.L., Tyrrell D.A. Effects of a "new" human respiratory virus in volunteers. Br. Med. J. 1967;3:767&#x2013;769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1843247</ArticleId><ArticleId IdType="pubmed">6043624</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai C., Peng Y., Shen E., Huang Q., Chen Y., Liu P., Guo C., Feng Z., Gao L., Zhang X., Gao Y., Liu Y., Han Y., Zeng S., Shen H. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines. Mol. Ther. 2021;29:2794&#x2013;2805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8342868</ArticleId><ArticleId IdType="pubmed">34365034</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Wang J., Jian F., Xiao T., Song W., Yisimayi A., Huang W., Li Q., Wang P., An R., Wang J., Wang Y., Niu X., Yang S., Liang H., Sun H., Li T., Yu Y., Cui Q., Liu S., Yang X., Du S., Zhang Z., Hao X., Shao F., Jin R., Wang X., Xiao J., Wang Y., Xie X.S. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602:657&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8866119</ArticleId><ArticleId IdType="pubmed">35016194</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Rajnik M., Aleem A., Dulebohn S., Di Napoli R. StatPearls; 2021. Features, Evaluation, and Treatment of Coronavirus (COVID-19)</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandler J.C., Bevins S.N., Ellis J.W., Linder T.J., Tell R.M., Jenkins-Moore M., Root J.J., Lenoch J.B., Robbe-Austerman S., DeLiberto T.J., Gidlewski T., Torchetti M.K., Shriner S.A. SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus) Proc. Natl. Acad. Sci. 2021;118</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8617405</ArticleId><ArticleId IdType="pubmed">34732584</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B., Choudhary M.C., Regan J., Sparks J.A., Padera R.F., Qiu X., Solomon I.H., Kuo H.H., Boucau J., Bowman K. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. 2020;383:2291&#x2013;2293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7673303</ArticleId><ArticleId IdType="pubmed">33176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J.Y., Smith D.M. SARS-CoV-2 variants of concern. Yonsei Med. J. 2021;62:961&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8542474</ArticleId><ArticleId IdType="pubmed">34672129</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhama K., Sharun K., Tiwari R., Dhawan M., Emran T.B., Rabaan A.A., Alhumaid S. COVID-19 vaccine hesitancy &#x2013; reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic. Hum. Vaccin. Immunother. 2021;17:3495&#x2013;3499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437517</ArticleId><ArticleId IdType="pubmed">34191680</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., Jbabdi S., Taschler B., Keating P., Winkler A.M., Collins R., Matthews P.M., Allen N., Miller K.L., Nichols T.E., Smith S.M. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022 doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Dro&#x17c;d&#x17c;al S., Rosik J., Lechowicz K., Machaj F., Szostak B., Przybyci&#x144;ski J., Lorzadeh S., Kotfis K., Ghavami S., &#x141;os M.J. An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resist. Updat. 2021 doi: 10.1016/j.drup.2021.100794:100794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drup.2021.100794:100794</ArticleId><ArticleId IdType="pmc">PMC8654464</ArticleId><ArticleId IdType="pubmed">34991982</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria N.R., Mellan T.A., Whittaker C., Claro I.M., DdS Candido, Mishra S., Crispim M.A., Sales F.C., Hawryluk I., McCrone J.T. Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021;372:815&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8139423</ArticleId><ArticleId IdType="pubmed">33853970</ArticleId></ArticleIdList></Reference><Reference><Citation>Forni D., Cagliani R., Clerici M., Sironi M. Molecular evolution of human coronavirus genomes. Trends Microbiol. 2017;25:35&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7111218</ArticleId><ArticleId IdType="pubmed">27743750</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung T.S., Liu D.X. Human coronavirus: host-pathogen interaction. Annu. Rev. Microbiol. 2019;73:529&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">31226023</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao G., Liu W., Liu P., Lei W., Jia Z., He X., Liu L-L, Shi W., Tan Y., Zou S. 2022. Surveillance of SARS-CoV-2 in the Environment and Animal Samples of the Huanan Seafood Market.</Citation></Reference><Reference><Citation>Garcia-Beltran W.F., Lam E.C., St. Denis K., Nitido A.D., Garcia Z.H., Hauser B.M., Feldman J., Pavlovic M.N., Gregory D.J., Poznansky M.C., Sigal A., Schmidt A.G., Iafrate A.J., Naranbhai V., Balazs A.B. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021 doi: 10.1016/j.cell.2021.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC8082941</ArticleId><ArticleId IdType="pubmed">33930298</ArticleId></ArticleIdList></Reference><Reference><Citation>Garigliany M., Van Laere A.S., Clercx C., Giet D., Escriou N., Huon C., Van Der Werf S., Eloit M., Desmecht D. SARS-CoV-2 natural transmission from human to cat, Belgium, March 2020. Emerg. Infect. Dis. 2020;26:3069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7706966</ArticleId><ArticleId IdType="pubmed">32788033</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg Y., Mandel M., Bar-On Y.M., Bodenheimer O., Freedman L., Haas E.J., Milo R., Alroy-Preis S., Ash N., Huppert A. Waning immunity after the BNT162b2 vaccine in Israel. N. Engl. J. Med. 2021;385:e85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609604</ArticleId><ArticleId IdType="pubmed">34706170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gribble J., Stevens L.J., Agostini M.L., Anderson-Daniels J., Chappell J.D., Lu X., Pruijssers A.J., Routh A.L., Denison M.R. The coronavirus proofreading exoribonuclease mediates extensive viral recombination. PLoS Pathog. 2021;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7846108</ArticleId><ArticleId IdType="pubmed">33465137</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamre D., Procknow J.J. A new virus isolated from the human respiratory tract. Proc. Soc. Exp. Biol. Med. 1966;121:190&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">4285768</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartenian E., Nandakumar D., Lari A., Ly M., Tucker J.M., Glaunsinger B.A. The molecular virology of coronaviruses. J. Biol. Chem. 2020;295:12910&#x2013;12934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489918</ArticleId><ArticleId IdType="pubmed">32661197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayawi K., Shahriar S., Serhani M.A., Alashwal H., Masud M.M. Vaccine versus variants (3Vs): are the COVID-19 vaccines effective against the variants? A systematic review . Vaccines. 2021;9:1305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8622454</ArticleId><ArticleId IdType="pubmed">34835238</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz F.X., Stiasny K. Profile of SARS-CoV-2. Wien. Klin. Wochenschr. 2020;132:635&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7597426</ArticleId><ArticleId IdType="pubmed">33125580</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Arora P., Gro&#xdf; R., Seidel A., H&#xf6;rnich B.F., Hahn A.S., Kr&#xfc;ger N., Graichen L., Hofmann-Winkler H., Kempf A., Winkler M.S., Schulz S., J&#xe4;ck H.M., Jahrsd&#xf6;rfer B., Schrezenmeier H., M&#xfc;ller M., Kleger A., M&#xfc;nch J., P&#xf6;hlmann S. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell. 2021;184:2384&#x2013;2393. e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7980144</ArticleId><ArticleId IdType="pubmed">33794143</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E.C. Oxford University Press; 2009. The Evolution and Emergence of RNA Viruses.</Citation></Reference><Reference><Citation>Holmes E.C., Goldstein S.A., Rasmussen A.L., Robertson D.L., Crits-Christoph A., Wertheim J.O., Anthony S.J., Barclay W.S., Boni M.F., Doherty P.C., Farrar J., Geoghegan J.L., Jiang X., Leibowitz J.L., Neil S.J.D., Skern T., Weiss S.R., Worobey M., Andersen K.G., Garry R.F., Rambaut A. The origins of SARS-CoV-2: a critical review. Cell. 2021;184:4848&#x2013;4856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8373617</ArticleId><ArticleId IdType="pubmed">34480864</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Yang C., Xu X-f, Xu W., Liu S-w. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol. Sin. 2020;41:1141&#x2013;1149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396720</ArticleId><ArticleId IdType="pubmed">32747721</ArticleId></ArticleIdList></Reference><Reference><Citation>Irigoyen N., Firth A.E., Jones J.D., Chung B.Y.-.W., Siddell S.G., Brierley I. High-resolution analysis of coronavirus gene expression by RNA sequencing and ribosome profiling. PLoS Pathog. 2016;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4769073</ArticleId><ArticleId IdType="pubmed">26919232</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayk Bernal A., Gomes da Silva M.M., Musungaie D.B., Kovalchuk E., Gonzalez A., Delos Reyes V., Mart&#xed;n-Quir&#xf3;s A., Caraco Y., Williams-Diaz A., Brown M.L., Du J., Pedley A., Assaid C., Strizki J., Grobler J.A., Shamsuddin H.H., Tipping R., Wan H., Paschke A., Butterton J.R., Johnson M.G., De Anda C. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients. N. Engl. J. Med. 2021 doi: 10.1056/NEJMoa2116044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2116044</ArticleId><ArticleId IdType="pmc">PMC8693688</ArticleId><ArticleId IdType="pubmed">34914868</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson N.P., Mueller J. Updating the accounts: global mortality of the 1918-1920" Spanish" influenza pandemic. Bull. Hist. Med. 2002:105&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">11875246</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim S.S.A., Karim Q.A. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet North Am. Ed. 2021;398:2126&#x2013;2128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8640673</ArticleId><ArticleId IdType="pubmed">34871545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke R., Romero-Severson E., Sanche S., Hengartner N. Estimating the reproductive number R0 of SARS-CoV-2 in the United States and eight European countries and implications for vaccination. J. Theor. Biol. 2021;517</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7880839</ArticleId><ArticleId IdType="pubmed">33587929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp S.A., Collier D.A., Datir R.P., Ferreira I.A., Gayed S., Jahun A., Hosmillo M., Rees-Spear C., Mlcochova P., Lumb I.U. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021;592:277&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610568</ArticleId><ArticleId IdType="pubmed">33545711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.-.E., Humphrey C.D., Shieh W.-.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.-.Y., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., Anderson L.J. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348:1953&#x2013;1966.</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Nyodu R., Maurya V.K., Saxena S.K. Coronavirus Disease 2019 (COVID-19): Epidemiology, Pathogenesis, Diagnosis, and Therapeutics. 2020. Morphology, genome organization, replication, and pathogenesis of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-15-4814-7_3:23-31</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupferschmidt K. American Association for the Advancement of Science; 2021. Where Did &#x2018;weird'Omicron come from?</Citation><ArticleIdList><ArticleId IdType="pubmed">34855502</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen H.D., Fonager J., Lomholt F.K., Dalby T., Benedetti G., Kristensen B., Urth T.R., Rasmussen M., Lassauni&#xe8;re R., Rasmussen T.B. Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020. Eurosurveillance. 2021;26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7863232</ArticleId><ArticleId IdType="pubmed">33541485</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin E.G., Lustig Y., Cohen C., Fluss R., Indenbaum V., Amit S., Doolman R., Asraf K., Mendelson E., Ziv A., Rubin C., Freedman L., Kreiss Y., Regev-Yochay G. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N. Engl. J. Med. 2021;385:e84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522797</ArticleId><ArticleId IdType="pubmed">34614326</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Giorgi E.E., Marichannegowda M.H., Foley B., Xiao C., Kong X.P., Chen Y., Gnanakaran S., Korber B., Gao F. Emergence of SARS-CoV-2 through recombination and strong purifying selection. Sci. Adv. 2020;6:eabb9153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7458444</ArticleId><ArticleId IdType="pubmed">32937441</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Gayle A.A., Wilder-Smith A., Rockl&#xf6;v J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7074654</ArticleId><ArticleId IdType="pubmed">32052846</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Liu J., Plante K.S., Plante J.A., Xie X., Zhang X., Ku Z., An Z., Scharton D., Schindewolf C., Widen S.G., Menachery V.D., Shi P.Y., Weaver S.C. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. Nature. 2022;602:294&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900207</ArticleId><ArticleId IdType="pubmed">34818667</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Rockl&#xf6;v J. The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus. J. Travel Med. 2021;28</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8436367</ArticleId><ArticleId IdType="pubmed">34369565</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Rockl&#xf6;v J. The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta. J. Travel Med. 2022;29</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8992231</ArticleId><ArticleId IdType="pubmed">35262737</ArticleId></ArticleIdList></Reference><Reference><Citation>Lytras S., Hughes J., Martin D., Swanepoel P., de Klerk A., Lourens R., Kosakovsky Pond S.L., Xia W., Jiang X., Robertson D.L. Exploring the natural origins of SARS-CoV-2 in the light of recombination. Genome Biol. Evol. 2022;14:evac018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882382</ArticleId><ArticleId IdType="pubmed">35137080</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ. 2021;375:n2713.</Citation><ArticleIdList><ArticleId IdType="pubmed">34750163</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu E., Ritchie H., Ortiz-Ospina E., Roser M., Hasell J., Appel C., Giattino C., Rod&#xe9;s-Guirao L. A global database of COVID-19 vaccinations. Nat. Hum. Behav. 2021;5:947&#x2013;953.</Citation><ArticleIdList><ArticleId IdType="pubmed">33972767</ArticleId></ArticleIdList></Reference><Reference><Citation>McAleer M.J. 2021. RE: SARS-CoV-2 Transmission Between Mink and Humans.</Citation></Reference><Reference><Citation>McAloose D., Laverack M., Wang L., Killian M.L., Caserta L.C., Yuan F., Mitchell P.K., Queen K., Mauldin M.R., Cronk B.D. From people to Panthera: natural SARS-CoV-2 infection in tigers and lions at the Bronx Zoo. MBio. 2020;11 e02220-20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7554670</ArticleId><ArticleId IdType="pubmed">33051368</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta O.P., Bhandari P., Raut A., Kacimi S.E.O., Huy N.T. Coronavirus disease (COVID-19): comprehensive review of clinical presentation. Front. Public Health. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844320</ArticleId><ArticleId IdType="pubmed">33520910</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens D.M., Taubenberger J.K., Fauci A.S. The persistent legacy of the 1918 influenza virus. N. Engl. J. Med. 2009;361:225&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2749954</ArticleId><ArticleId IdType="pubmed">19564629</ArticleId></ArticleIdList></Reference><Reference><Citation>Munnink B.B.O., Sikkema R.S., Nieuwenhuijse D.F., Molenaar R.J., Munger E., Molenkamp R., Avd Spek, Tolsma P., Rietveld A., Brouwer M., Bouwmeester-Vincken N., Harders F., Honing RH-vd, Wegdam-Blans M.C.A., Bouwstra R.J., GeurtsvanKessel C., AAvd Eijk, Velkers F.C., Smit L.A.M., Stegeman A., WHMvd Poel, Koopmans M.P.G. Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science. 2021;371:172&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857398</ArticleId><ArticleId IdType="pubmed">33172935</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M.I., Gramer M.R., Vincent A.L., Holmes E.C. Global transmission of influenza viruses from humans to swine. J. Gen. Virol. 2012;93:2195&#x2013;2203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3541789</ArticleId><ArticleId IdType="pubmed">22791604</ArticleId></ArticleIdList></Reference><Reference><Citation>Omrani A.S., Zaqout A., Baiou A., Daghfal J., Elkum N., Alattar R.A., Bakdach D., Abusriwil H., Mostafa A.M., Alhariri B., Ambra N., Khatib M., Eldeeb A.M., Merenkov Z., Fawzi Z., Hmissi S.M., Hssain A.A., Coyle P.V., Alsoub H., Almaslamani M.A., Alkhal A. Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: a preliminary report. J. Med. Virol. 2021;93:1678&#x2013;1686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537323</ArticleId><ArticleId IdType="pubmed">32965715</ArticleId></ArticleIdList></Reference><Reference><Citation>Oreshkova N., Molenaar R.J., Vreman S., Harders F., Munnink B.B.O., Hakze-van Der Honing R.W., Gerhards N., Tolsma P., Bouwstra R., Sikkema R.S. SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020. Eurosurveillance. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403642</ArticleId><ArticleId IdType="pubmed">32553059</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto S.P., Day T., Arino J., Colijn C., Dushoff J., Li M., Mechai S., Van Domselaar G., Wu J., Earn D.J.D., Ogden N.H. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Curr. Biol. 2021;31:R918&#x2013;R929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220957</ArticleId><ArticleId IdType="pubmed">34314723</ArticleId></ArticleIdList></Reference><Reference><Citation>Paules C.I., Marston H.D., Fauci A.S. Coronavirus infections-more than just the common cold. JAMA. 2020;323:707&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">31971553</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlman S., Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 2009;7:439&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2830095</ArticleId><ArticleId IdType="pubmed">19430490</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen E., Koopmans M., Go U., Hamer D.H., Petrosillo N., Castelli F., Storgaard M., Al Khalili S., Simonsen L. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect. Dis. 2020;20:e238&#x2013;e244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333991</ArticleId><ArticleId IdType="pubmed">32628905</ArticleId></ArticleIdList></Reference><Reference><Citation>Planas D., Saunders N., Maes P., Guivel-Benhassine F., Planchais C., Buchrieser J., Bolland W.H., Porrot F., Staropoli I., Lemoine F., P&#xe9;r&#xe9; H., Veyer D., Puech J., Rodary J., Baele G., Dellicour S., Raymenants J., Gorissen S., Geenen C., Vanmechelen B., Wawina-Bokalanga T., Mart&#xed;-Carreras J., Cuypers L., S&#xe8;ve A., Hocqueloux L., Prazuck T., Rey F.A., Simon-Loriere E., Bruel T., Mouquet H., Andr&#xe9; E., Schwartz O. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602:671&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pubmed">35016199</ArticleId></ArticleIdList></Reference><Reference><Citation>Plante J.A., Liu Y., Liu J., Xia H., Johnson B.A., Lokugamage K.G., Zhang X., Muruato A.E., Zou J., Fontes-Garfias C.R., Mirchandani D., Scharton D., Bilello J.P., Ku Z., An Z., Kalveram B., Freiberg A.N., Menachery V.D., Xie X., Plante K.S., Weaver S.C., Shi P.-.Y. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592:116&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158177</ArticleId><ArticleId IdType="pubmed">33106671</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevention CfDCa  . 2022. Omicron Variant: What You Need to Know.https://www.cdc.gov/coronavirus/2019-ncov/variants/omicron-variant.html Accessed March 4.</Citation></Reference><Reference><Citation>Prussia A., Thepchatri P., Snyder J.P., Plemper R.K. Systematic approaches towards the development of host-directed antiviral therapeutics. Int. J. Mol. Sci. 2011;12:4027&#x2013;4052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3131607</ArticleId><ArticleId IdType="pubmed">21747723</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzberger B., Buder F., Lampl B., Ehrenstein B., Hitzenbichler F., Holzmann T., Schmidt B., Hanses F. Epidemiology of SARS-CoV-2. Infection. 2021;49:233&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543961</ArticleId><ArticleId IdType="pubmed">33034020</ArticleId></ArticleIdList></Reference><Reference><Citation>Self W.H., Tenforde M.W., Rhoads J.P., Gaglani M., Ginde A.A., Douin D.J., Olson S.M., Talbot H.K., Casey J.D., Mohr N.M., Zepeski A., McNeal T., Ghamande S., Gibbs K.W., Files D.C., Hager D.N., Shehu A., Prekker M.E., Erickson H.L., Gong M.N., Mohamed A., Henning D.J., Steingrub J.S., Peltan I.D., Brown S.M., Martin E.T., Monto A.S., Khan A., Hough C.L., Busse L.W., Ten Lohuis C.C., Duggal A., Wilson J.G., Gordon A.J., Qadir N., Chang S.Y., Mallow C., Rivas C., Babcock H.M., Kwon J.H., Exline M.C., Halasa N., Chappell J.D., Lauring A.S., Grijalva C.G., Rice T.W., Jones I.D., Stubblefield W.B., Baughman A., Womack K.N., et al. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson &amp; Johnson) Vaccines in Preventing COVID-19 hospitalizations among adults without immunocompromising conditions - United States, March-August 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1337&#x2013;1343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459899</ArticleId><ArticleId IdType="pubmed">34555004</ArticleId></ArticleIdList></Reference><Reference><Citation>Setoh Y.X., Amarilla A.A., Peng N.Y., Griffiths R.E., Carrera J., Freney M.E., Nakayama E., Ogawa S., Watterson D., Modhiran N. Determinants of Zika virus host tropism uncovered by deep mutational scanning. Nat. Microbiol. 2019;4:876&#x2013;887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6667831</ArticleId><ArticleId IdType="pubmed">30886357</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A.S.V., Gribben C., Bishop J., Hanlon P., Caldwell D., Wood R., Reid M., McMenamin J., Goldberg D., Stockton D., Hutchinson S., Robertson C., McKeigue P.M., Colhoun H.M., McAllister D.A. Effect of vaccination on transmission of SARS-CoV-2. N. Engl. J. Med. 2021;385:1718&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8451182</ArticleId><ArticleId IdType="pubmed">34496200</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan K.J., Wei C., Wang Y., Huan Q., Qian W. Host-specific asymmetric accumulation of mutation types reveals that the origin of SARS-CoV-2 is consistent with a natural process. Innovation. 2021;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8405235</ArticleId><ArticleId IdType="pubmed">34485968</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon-Loriere E., Holmes E.C. Why do RNA viruses recombine? Nat. Rev. Microbiol. 2011;9:617&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3324781</ArticleId><ArticleId IdType="pubmed">21725337</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D., Yi S.V. On the origin and evolution of SARS-CoV-2. Exp. Mol. Med. 2021;53:537&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050477</ArticleId><ArticleId IdType="pubmed">33864026</ArticleId></ArticleIdList></Reference><Reference><Citation>Sit T.H., Brackman C.J., Ip S.M., Tam K.W., Law P.Y., To E.M., Yu V.Y., Sims L.D., Tsang D.N., Chu D.K. Infection of dogs with SARS-CoV-2. Nature. 2020;586:776&#x2013;778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606701</ArticleId><ArticleId IdType="pubmed">32408337</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.C., Blanc H., Vignuzzi M., Denison M.R. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog. 2013;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3744431</ArticleId><ArticleId IdType="pubmed">23966862</ArticleId></ArticleIdList></Reference><Reference><Citation>Sola I., Almaz&#xe1;n F., Z&#xfa;&#xf1;iga S., Enjuanes L. Continuous and discontinuous RNA synthesis in coronaviruses. Annu. Rev. Virol. 2015;2:265&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6025776</ArticleId><ArticleId IdType="pubmed">26958916</ArticleId></ArticleIdList></Reference><Reference><Citation>Song P., Li W., Xie J., Hou Y., You C. Cytokine storm induced by SARS-CoV-2. Clin. Chim. Acta. 2020;509:280&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283076</ArticleId><ArticleId IdType="pubmed">32531256</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr T.N., Greaney A.J., Hilton S.K., Ellis D., Crawford K.H.D., Dingens A.S., Navarro M.J., Bowen J.E., Tortorici M.A., Walls A.C., King N.P., Veesler D., Bloom J.D. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell. 2020;182:1295&#x2013;1310. e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418704</ArticleId><ArticleId IdType="pubmed">32841599</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S., Wong G., Shi W., Liu J., Lai A.C.K., Zhou J., Liu W., Bi Y., Gao G.F. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24:490&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125511</ArticleId><ArticleId IdType="pubmed">27012512</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K., Tzou P.L., Nouhin J., Gupta R.K., de Oliveira T., Kosakovsky Pond S.L., Fera D., Shafer R.W. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat. Rev. Genet. 2021;22:757&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447121</ArticleId><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartof S.Y., Slezak J.M., Fischer H., Hong V., Ackerson B.K., Ranasinghe O.N., Frankland T.B., Ogun O.A., Zamparo J.M., Gray S., Valluri S.R., Pan K., Angulo F.J., Jodar L., McLaughlin J.M. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet N. Am. Ed. 2021;398:1407&#x2013;1416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8489881</ArticleId><ArticleId IdType="pubmed">34619098</ArticleId></ArticleIdList></Reference><Reference><Citation>Team CC-VBCI COVID-19 vaccine breakthrough infections reported to CDC - United States, January 1-April 30, 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:792&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158893</ArticleId><ArticleId IdType="pubmed">34043615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegally H., Wilkinson E., Giovanetti M., Iranzadeh A., Fonseca V., Giandhari J., Doolabh D., Pillay S., San E.J., Msomi N., Mlisana K., von Gottberg A., Walaza S., Allam M., Ismail A., Mohale T., Glass A.J., Engelbrecht S., Van Zyl G., Preiser W., Petruccione F., Sigal A., Hardie D., Marais G., Hsiao N.Y., Korsman S., Davies M.A., Tyers L., Mudau I., York D., Maslo C., Goedhals D., Abrahams S., Laguda-Akingba O., Alisoltani-Dehkordi A., Godzik A., Wibmer C.K., Sewell B.T., Louren&#xe7;o J., Alcantara L.C.J., Kosakovsky Pond S.L., Weaver S., Martin D., Lessells R.J., Bhiman J.N., Williamson C., de Oliveira T. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021;592:438&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">33690265</ArticleId></ArticleIdList></Reference><Reference><Citation>Teruel N., Mailhot O., Najmanovich R.J. Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants. PLoS Comput. Biol. 2021;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384204</ArticleId><ArticleId IdType="pubmed">34351895</ArticleId></ArticleIdList></Reference><Reference><Citation>Thi Nhu Thao T., Labroussaa F., Ebert N., V'kovski P., Stalder H., Portmann J., Kelly J., Steiner S., Holwerda M., Kratzel A., Gultom M., Schmied K., Laloli L., H&#xfc;sser L., Wider M., Pfaender S., Hirt D., Cipp&#xe0; V., Crespo-Pomar S., Schr&#xf6;der S., Muth D., Niemeyer D., Corman V.M., M&#xfc;ller M.A., Drosten C., Dijkman R., Jores J., Thiel V. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature. 2020;582:561&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">32365353</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian D., Sun Y., Xu H., Ye Q. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J. Med. Virol. 2022;94:2376&#x2013;2383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9015498</ArticleId><ArticleId IdType="pubmed">35118687</ArticleId></ArticleIdList></Reference><Reference><Citation>Torii S., Ono C., Suzuki R., Morioka Y., Anzai I., Fauzyah Y., Maeda Y., Kamitani W., Fukuhara T., Matsuura Y. Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction. Cell Rep. 2021;35</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015404</ArticleId><ArticleId IdType="pubmed">33838744</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend J.P., Hassler H.B., Wang Z., Miura S., Singh J., Kumar S., Ruddle N.H., Galvani A.P., Dornburg A. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. Lancet Microbe. 2021;2:e666&#x2013;e675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486316</ArticleId><ArticleId IdType="pubmed">34632431</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong T.T., Ryutov A., Pandey U., Yee R., Goldberg L., Bhojwani D., Aguayo-Hiraldo P., Pinsky B.A., Pekosz A., Shen L. MedRxiv; 2021. Persistent SARS-CoV-2 Infection and Increasing Viral Variants in Children and Young Adults With Impaired Humoral Immunity.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072072</ArticleId><ArticleId IdType="pubmed">33915337</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyrrell D.A., Almeida J.D., Cunningham C.H., Dowdle W.R., Hofstad M.S., McIntosh K., Tajima M., Zakstelskaya L.Y., Easterday B.C., Kapikian A., Bingham R.W. Coronaviridae. Intervirology. 1975;5:76&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182643</ArticleId><ArticleId IdType="pubmed">1184350</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyrrell D.A.J., Bynoe M.L. Cultivation of viruses from a high proportion of patients with colds. Lancet N. Am. Ed. 1966;287:76&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">4158999</ArticleId></ArticleIdList></Reference><Reference><Citation>U. S. Food and Drug Administration  . 2021. Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults.https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19-certain Accessed December 29.</Citation></Reference><Reference><Citation>U. S. Food and Drug Administration  . 2021. Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19.https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19 Accessed December 29.</Citation></Reference><Reference><Citation>U. S. Food and Drug Administration . 2021. Coronavirus Disease 2019 (COVID-19) Emergency Use Authorization Information. Accessed April 16.</Citation><ArticleIdList><ArticleId IdType="pubmed">34097371</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Health Secruity Agency  . UK Health Security Agency; Agency UHS: 2022. The Effectiveness of Vaccination Against Long covid: a Rapid Evidence Briefing.https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-retrieve-file.pl?id=fe4f10cd3cd509fe045ad4f72ae0dfff UK Health Security Agency.</Citation></Reference><Reference><Citation>Ulloa A.C., Buchan S.A., Daneman N., Brown K.A. Estimates of SARS-CoV-2 Omicron variant severity in Ontario, Canada. JAMA. 2022 doi: 10.1001/jama.2022.2274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.2274</ArticleId><ArticleId IdType="pmc">PMC8855311</ArticleId><ArticleId IdType="pubmed">35175280</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kampen J.J., van de Vijver D.A., Fraaij P.L., Haagmans B.L., Lamers M.M., Okba N., van den Akker J.P., Endeman H., Gommers D.A., Cornelissen J.J. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) Nat. Commun. 2021;12:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801729</ArticleId><ArticleId IdType="pubmed">33431879</ArticleId></ArticleIdList></Reference><Reference><Citation>V'kovski P., Kratzel A., Steiner S., Stalder H., Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 2021;19:155&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Didelot X., Bi Y., Gao G.F. Assessing the extent of community spread caused by mink-derived SARS-CoV-2 variants. Innovation. 2021;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8182980</ArticleId><ArticleId IdType="pubmed">34124706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054408</ArticleId><ArticleId IdType="pubmed">32020029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C., Shan K.J., Wang W., Zhang S., Huan Q., Qian W. Evidence for a mouse origin of the SARS-CoV-2 Omicron variant. J. Genet. Genomics. 2021;48:1111&#x2013;1121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8702434</ArticleId><ArticleId IdType="pubmed">34954396</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigang S., Fuchs J., Zimmer G., Schnepf D., Kern L., Beer J., Luxenburger H., Ankerhold J., Falcone V., Kemming J., Hofmann M., Thimme R., Neumann-Haefelin C., Ulferts S., Grosse R., Hornuss D., Tanriver Y., Rieg S., Wagner D., Huzly D., Schwemmle M., Panning M., Kochs G. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants. Nat. Commun. 2021;12:6405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8568958</ArticleId><ArticleId IdType="pubmed">34737266</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Solidarity Trial Consortium Repurposed Antiviral Drugs for Covid-19 &#x2014; Interim WHO solidarity trial results. N. Engl. J. Med. 2020;384:497&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727327</ArticleId><ArticleId IdType="pubmed">33264556</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson B.N., Feldmann F., Schwarz B., Meade-White K., Porter D.P., Schulz J., van Doremalen N., Leighton I., Yinda C.K., P&#xe9;rez-P&#xe9;rez L., Okumura A., Lovaglio J., Hanley P.W., Saturday G., Bosio C.M., Anzick S., Barbian K., Cihlar T., Martens C., Scott D.P., Munster V.J., de Wit E. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature. 2020;585:273&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486271</ArticleId><ArticleId IdType="pubmed">32516797</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolter N., Jassat W., Walaza S., Welch R., Moultrie H., Groome M., Amoako D.G., Everatt J., Bhiman J.N., Scheepers C., Tebeila N., Chiwandire N., du Plessis M., Govender N., Ismail A., Glass A., Mlisana K., Stevens W., Treurnicht F.K., Makatini Z., Hsiao N.Y., Parboosing R., Wadula J., Hussey H., Davies M.A., Boulle A., von Gottberg A., Cohen C. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet N. Am. Ed. 2022;399:437&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8769664</ArticleId><ArticleId IdType="pubmed">35065011</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Draft Landscape of COVID-19 Candidate Vaccines. 2020. WHO; 2020. https://www who int/publications/m/item/dr aft-landscape-of-covid-19-candidatevaccines.</Citation></Reference><Reference><Citation>World Health Organization . Coronavirus disease (COVID-19) pandemic. WHO; 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey={adgroupsurvey}&amp;gclid=Cj0KCQjw3duCBhCAARIsAJeFyPVP4p0r14yN_2HpjV-o41tjm-tgNevnt8zlPNIqD401Zkb6bM8ND5UaAg4qEALw_wcB. Accessed March 21.</Citation></Reference><Reference><Citation>World Health Organization  . 2021. Middle East Respiratory Coronavirus.https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers#tab=tab_1 Accessed.</Citation></Reference><Reference><Citation>World Health Organization  . 2022. Tracking SARS-CoV-2 Variants.https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ Accessed April 7.</Citation><ArticleIdList><ArticleId IdType="pubmed">37184162</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  . 2022. Severe Acute Respiratory Syndrome (SARS)https://www.who.int/health-topics/severe-acute-respiratory-syndrome#tab=tab_1 Accessed.</Citation></Reference><Reference><Citation>Worobey M., Levy J.I., MS L.M., Crits-Christoph A., Pekar J.E., Goldstein S.A., Rasmussen A.L., Kraemer M.U.G., Newman C., Koopmans M.P.G., Suchard M.A., Wertheim J.O., Lemey P., Robertson D.L., Garry R.F., Holmes E.C., Rambaut A., Andersen K.G. The Huanan market was the epicenter of SARS-CoV-2 emergence. Zenodo. 2022 doi: 10.5281/zenodo.6299600.</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.6299600</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X., Lokugamage K.G., Zhang X., Vu M.N., Muruato A.E., Menachery V.D., Shi P.Y. Engineering SARS-CoV-2 using a reverse genetic system. Nat. Protoc. 2021;16:1761&#x2013;1784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168523</ArticleId><ArticleId IdType="pubmed">33514944</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T.J., Yu P.Y., Chang Y.C., Liang K.H., Tso H.C., Ho M.R., Chen W.Y., Lin H.T., Wu H.C., Hsu S.T.D. Effect of SARS-CoV-2 B 1.1. 7 mutations on spike protein structure and function. Nat. Struct. Mol. Biol. 2021;28:731&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">34385690</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Y., Zhang Q., Wei X., Cao Z., Yuan H.Y., Zeng D.D. Equitable access to COVID-19 vaccines makes a life-saving difference to all countries. Nature Human Behaviour. 2022;6:207&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8873023</ArticleId><ArticleId IdType="pubmed">35102361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z.W., Yuan S., Yuen K.S., Fung S.Y., Chan C.P., Jin D.Y. Zoonotic origins of human coronaviruses. Int. J. Biol. Sci. 2020;16:1686&#x2013;1697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7098031</ArticleId><ArticleId IdType="pubmed">32226286</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki A.M., Van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012;367:1814&#x2013;1820.</Citation><ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Jackson C.B., Mou H., Ojha A., Peng H., Quinlan B.D., Rangarajan E.S., Pan A., Vanderheiden A., Suthar M.S., Li W., Izard T., Rader C., Farzan M., Choe H. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat. Commun. 2020;11:6013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693302</ArticleId><ArticleId IdType="pubmed">33243994</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Ji J., Chen X., Bi Y., Li J., Wang Q., Hu T., Song H., Zhao R., Chen Y. Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses. Cell. 2021;184 4380&#x2013;4391. e14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188299</ArticleId><ArticleId IdType="pubmed">34147139</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>